the UK in 2015 and was followed by the Android equivalent in May 2016.
Hendrik Kleinsmiede, the director of Visa Europe's innovation arm Collab, which is backing Sthaler, said the Fingopay technology was less immune to problems such as wet and dusty fingers or fraud. "People are ready to accept biometrics as a secure authentication mechanism," he said.
Sthaler says the chance that two people have the same vein structure is 3.4bn-to-one, making it virtually impossible to crack. The vein scanner, developed by Hitachi, is already being used by Barclays to identify business customers as well as in cash machines in Japan, but Sthaler has the unique rights to license it to retailers.
In the trial at Proud set to begin in September, the technology will be used to speed up waiting times at the bar both by cutting down on cards and by being able to suggest drinks based on what a patron has previously ordered.
7. Which of the following is TRUE about Fingopay?
A. It works by identifying shoppers' fingerprints.
B. It scans the finger veins to identify shoppers.
C. It was first tested on Barclays' cash machines in Japan.
D. It is currently being tested in the Co-op Group's food stores.
8. According to Hendrik Kleinsmiede, .
A. it is impossible to find two people who share the same vein structure
B. people have to clean their hands before they use Fingopay
C. it won't be long before biometrics are more widely used
D. Fingopay technology is much more effective than passwords and PINs
9. What can we conclude from the last paragraph?
A. The use of Fingopay technology has bought in more customers.
B. Fingopay technology helps businesses to meet customers' needs.
C. Fingopay technology could increase the sales of certain drinks.
D. The use of Fingopay technology wasn't allowed in the trial at Proud.
10. What might be the best title of the passage?
A. Pay with your vein: Fingopay.
B. Cedit cards vs. Fingopay.
C. Different ways of payment.
D. A new technology: fingerprints.